Psychedelic Treatment for PTSD Sees a Setback with FDA Rejection

Despite years of promising results with using psychedelic treatments to help people with conditions such as depression or PTSD, the treatment finally saw its day in front of the FDA. It didn’t go well. Citing concerns about safety, the FDA rejected the use of psychedelics to treat PTSD.

While the rejection is a serious setback for the promising pace of psychedelic research, the main reason for the rejection is even more interesting. Typically, a drug is tested through a series of controlled b...